Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Salmeterol+fluticasone propionate |
Is a |
Product containing beta-2 adrenergic receptor agonist (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
Is a |
Medicinal product acting as bronchodilator (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
Is a |
Product containing salmeterol (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
Is a |
Fluticasone propionate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Fluticasone propionate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Salmeterol (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Salmeterol+fluticasone propionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|